Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global AI In Cancer Diagnostics Market, by End-user
1.4.2 Global AI In Cancer Diagnostics Market, by Component
1.4.3 Global AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 Global AI In Cancer Diagnostics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
Chapter 4. Global AI In Cancer Diagnostics Market by End-user
4.1 Global Hospital Market by Region
4.2 Global Surgical Centers & Medical Institutes Market by Region
4.3 Global Others Market by Region
Chapter 5. Global AI In Cancer Diagnostics Market by Component
5.1 Global Software Solutions Market by Region
5.2 Global Hardware Market by Region
5.3 Global Services Market by Region
Chapter 6. Global AI In Cancer Diagnostics Market by Cancer Type
6.1 Global Breast Cancer Market by Region
6.2 Global Lung Cancer Market by Region
6.3 Global Brain Tumor Market by Region
6.4 Global Skin Cancer & Cervical Cancer Market by Region
6.5 Global Prostate & Colorectal Cancer Market by Region
6.6 Global Others Market by Region
Chapter 7. Global AI In Cancer Diagnostics Market by Region
7.1 North America AI In Cancer Diagnostics Market
7.1.1 North America AI In Cancer Diagnostics Market by End-user
7.1.1.1 North America Hospital Market by Country
7.1.1.2 North America Surgical Centers & Medical Institutes Market by Country
7.1.1.3 North America Others Market by Country
7.1.2 North America AI In Cancer Diagnostics Market by Component
7.1.2.1 North America Software Solutions Market by Country
7.1.2.2 North America Hardware Market by Country
7.1.2.3 North America Services Market by Country
7.1.3 North America AI In Cancer Diagnostics Market by Cancer Type
7.1.3.1 North America Breast Cancer Market by Country
7.1.3.2 North America Lung Cancer Market by Country
7.1.3.3 North America Brain Tumor Market by Country
7.1.3.4 North America Skin Cancer & Cervical Cancer Market by Country
7.1.3.5 North America Prostate & Colorectal Cancer Market by Country
7.1.3.6 North America Others Market by Country
7.1.4 North America AI In Cancer Diagnostics Market by Country
7.1.4.1 US AI In Cancer Diagnostics Market
7.1.4.1.1 US AI In Cancer Diagnostics Market by End-user
7.1.4.1.2 US AI In Cancer Diagnostics Market by Component
7.1.4.1.3 US AI In Cancer Diagnostics Market by Cancer Type
7.1.4.2 Canada AI In Cancer Diagnostics Market
7.1.4.2.1 Canada AI In Cancer Diagnostics Market by End-user
7.1.4.2.2 Canada AI In Cancer Diagnostics Market by Component
7.1.4.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
7.1.4.3 Mexico AI In Cancer Diagnostics Market
7.1.4.3.1 Mexico AI In Cancer Diagnostics Market by End-user
7.1.4.3.2 Mexico AI In Cancer Diagnostics Market by Component
7.1.4.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
7.1.4.4 Rest of North America AI In Cancer Diagnostics Market
7.1.4.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
7.1.4.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
7.1.4.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
7.2 Europe AI In Cancer Diagnostics Market
7.2.1 Europe AI In Cancer Diagnostics Market by End-user
7.2.1.1 Europe Hospital Market by Country
7.2.1.2 Europe Surgical Centers & Medical Institutes Market by Country
7.2.1.3 Europe Others Market by Country
7.2.2 Europe AI In Cancer Diagnostics Market by Component
7.2.2.1 Europe Software Solutions Market by Country
7.2.2.2 Europe Hardware Market by Country
7.2.2.3 Europe Services Market by Country
7.2.3 Europe AI In Cancer Diagnostics Market by Cancer Type
7.2.3.1 Europe Breast Cancer Market by Country
7.2.3.2 Europe Lung Cancer Market by Country
7.2.3.3 Europe Brain Tumor Market by Country
7.2.3.4 Europe Skin Cancer & Cervical Cancer Market by Country
7.2.3.5 Europe Prostate & Colorectal Cancer Market by Country
7.2.3.6 Europe Others Market by Country
7.2.4 Europe AI In Cancer Diagnostics Market by Country
7.2.4.1 Germany AI In Cancer Diagnostics Market
7.2.4.1.1 Germany AI In Cancer Diagnostics Market by End-user
7.2.4.1.2 Germany AI In Cancer Diagnostics Market by Component
7.2.4.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
7.2.4.2 UK AI In Cancer Diagnostics Market
7.2.4.2.1 UK AI In Cancer Diagnostics Market by End-user
7.2.4.2.2 UK AI In Cancer Diagnostics Market by Component
7.2.4.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
7.2.4.3 France AI In Cancer Diagnostics Market
7.2.4.3.1 France AI In Cancer Diagnostics Market by End-user
7.2.4.3.2 France AI In Cancer Diagnostics Market by Component
7.2.4.3.3 France AI In Cancer Diagnostics Market by Cancer Type
7.2.4.4 Russia AI In Cancer Diagnostics Market
7.2.4.4.1 Russia AI In Cancer Diagnostics Market by End-user
7.2.4.4.2 Russia AI In Cancer Diagnostics Market by Component
7.2.4.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
7.2.4.5 Spain AI In Cancer Diagnostics Market
7.2.4.5.1 Spain AI In Cancer Diagnostics Market by End-user
7.2.4.5.2 Spain AI In Cancer Diagnostics Market by Component
7.2.4.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
7.2.4.6 Italy AI In Cancer Diagnostics Market
7.2.4.6.1 Italy AI In Cancer Diagnostics Market by End-user
7.2.4.6.2 Italy AI In Cancer Diagnostics Market by Component
7.2.4.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
7.2.4.7 Rest of Europe AI In Cancer Diagnostics Market
7.2.4.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
7.2.4.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
7.2.4.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
7.3 Asia Pacific AI In Cancer Diagnostics Market
7.3.1 Asia Pacific AI In Cancer Diagnostics Market by End-user
7.3.1.1 Asia Pacific Hospital Market by Country
7.3.1.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
7.3.1.3 Asia Pacific Others Market by Country
7.3.2 Asia Pacific AI In Cancer Diagnostics Market by Component
7.3.2.1 Asia Pacific Software Solutions Market by Country
7.3.2.2 Asia Pacific Hardware Market by Country
7.3.2.3 Asia Pacific Services Market by Country
7.3.3 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
7.3.3.1 Asia Pacific Breast Cancer Market by Country
7.3.3.2 Asia Pacific Lung Cancer Market by Country
7.3.3.3 Asia Pacific Brain Tumor Market by Country
7.3.3.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
7.3.3.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
7.3.3.6 Asia Pacific Others Market by Country
7.3.4 Asia Pacific AI In Cancer Diagnostics Market by Country
7.3.4.1 China AI In Cancer Diagnostics Market
7.3.4.1.1 China AI In Cancer Diagnostics Market by End-user
7.3.4.1.2 China AI In Cancer Diagnostics Market by Component
7.3.4.1.3 China AI In Cancer Diagnostics Market by Cancer Type
7.3.4.2 Japan AI In Cancer Diagnostics Market
7.3.4.2.1 Japan AI In Cancer Diagnostics Market by End-user
7.3.4.2.2 Japan AI In Cancer Diagnostics Market by Component
7.3.4.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
7.3.4.3 India AI In Cancer Diagnostics Market
7.3.4.3.1 India AI In Cancer Diagnostics Market by End-user
7.3.4.3.2 India AI In Cancer Diagnostics Market by Component
7.3.4.3.3 India AI In Cancer Diagnostics Market by Cancer Type
7.3.4.4 South Korea AI In Cancer Diagnostics Market
7.3.4.4.1 South Korea AI In Cancer Diagnostics Market by End-user
7.3.4.4.2 South Korea AI In Cancer Diagnostics Market by Component
7.3.4.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
7.3.4.5 Singapore AI In Cancer Diagnostics Market
7.3.4.5.1 Singapore AI In Cancer Diagnostics Market by End-user
7.3.4.5.2 Singapore AI In Cancer Diagnostics Market by Component
7.3.4.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
7.3.4.6 Malaysia AI In Cancer Diagnostics Market
7.3.4.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
7.3.4.6.2 Malaysia AI In Cancer Diagnostics Market by Component
7.3.4.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
7.3.4.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
7.3.4.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
7.3.4.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
7.3.4.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
7.4 LAMEA AI In Cancer Diagnostics Market
7.4.1 LAMEA AI In Cancer Diagnostics Market by End-user
7.4.1.1 LAMEA Hospital Market by Country
7.4.1.2 LAMEA Surgical Centers & Medical Institutes Market by Country
7.4.1.3 LAMEA Others Market by Country
7.4.2 LAMEA AI In Cancer Diagnostics Market by Component
7.4.2.1 LAMEA Software Solutions Market by Country
7.4.2.2 LAMEA Hardware Market by Country
7.4.2.3 LAMEA Services Market by Country
7.4.3 LAMEA AI In Cancer Diagnostics Market by Cancer Type
7.4.3.1 LAMEA Breast Cancer Market by Country
7.4.3.2 LAMEA Lung Cancer Market by Country
7.4.3.3 LAMEA Brain Tumor Market by Country
7.4.3.4 LAMEA Skin Cancer & Cervical Cancer Market by Country
7.4.3.5 LAMEA Prostate & Colorectal Cancer Market by Country
7.4.3.6 LAMEA Others Market by Country
7.4.4 LAMEA AI In Cancer Diagnostics Market by Country
7.4.4.1 Brazil AI In Cancer Diagnostics Market
7.4.4.1.1 Brazil AI In Cancer Diagnostics Market by End-user
7.4.4.1.2 Brazil AI In Cancer Diagnostics Market by Component
7.4.4.1.3 Brazil AI In Cancer Diagnostics Market by Cancer Type
7.4.4.2 Argentina AI In Cancer Diagnostics Market
7.4.4.2.1 Argentina AI In Cancer Diagnostics Market by End-user
7.4.4.2.2 Argentina AI In Cancer Diagnostics Market by Component
7.4.4.2.3 Argentina AI In Cancer Diagnostics Market by Cancer Type
7.4.4.3 UAE AI In Cancer Diagnostics Market
7.4.4.3.1 UAE AI In Cancer Diagnostics Market by End-user
7.4.4.3.2 UAE AI In Cancer Diagnostics Market by Component
7.4.4.3.3 UAE AI In Cancer Diagnostics Market by Cancer Type
7.4.4.4 Saudi Arabia AI In Cancer Diagnostics Market
7.4.4.4.1 Saudi Arabia AI In Cancer Diagnostics Market by End-user
7.4.4.4.2 Saudi Arabia AI In Cancer Diagnostics Market by Component
7.4.4.4.3 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type
7.4.4.5 South Africa AI In Cancer Diagnostics Market
7.4.4.5.1 South Africa AI In Cancer Diagnostics Market by End-user
7.4.4.5.2 South Africa AI In Cancer Diagnostics Market by Component
7.4.4.5.3 South Africa AI In Cancer Diagnostics Market by Cancer Type
7.4.4.6 Nigeria AI In Cancer Diagnostics Market
7.4.4.6.1 Nigeria AI In Cancer Diagnostics Market by End-user
7.4.4.6.2 Nigeria AI In Cancer Diagnostics Market by Component
7.4.4.6.3 Nigeria AI In Cancer Diagnostics Market by Cancer Type
7.4.4.7 Rest of LAMEA AI In Cancer Diagnostics Market
7.4.4.7.1 Rest of LAMEA AI In Cancer Diagnostics Market by End-user
7.4.4.7.2 Rest of LAMEA AI In Cancer Diagnostics Market by Component
7.4.4.7.3 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.4.2.2 Acquisition and Mergers:
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Product Launches and Product Expansions:
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
